BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2801828
Number of visits today
343
Number of downloads
2055768
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Xiong W, Li C, Wan B, Zheng Z, Zhang Y, Wang S, Fan J. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma. Front Immunol 2022;13:819080. [DOI: 10.3389/fimmu.2022.819080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Pan J, Huang T, Deng Z, Zou C. Roles and therapeutic implications of m6A modification in cancer immunotherapy. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1132601] [Reference Citation Analysis]
2 Ouyang Y, Tu Y, Chen S, Min H, Wen Z, Zheng G, Wan T, Fan H, Yang W, Sun G. Characterization of immune microenvironment infiltration and m(6)A regulator-mediated RNA methylation modification patterns in osteoarthritis. Front Immunol 2022;13:1018701. [PMID: 36505479 DOI: 10.3389/fimmu.2022.1018701] [Reference Citation Analysis]
3 Wang S, Ding B, Wang S, Yan W, Xia Q, Meng D, Xie S, Shen S, Yu B, Liu H, Hu J, Zhang X. Gene signature of m(6)A RNA regulators in diagnosis, prognosis, treatment, and immune microenvironment for cervical cancer. Sci Rep 2022;12:17667. [PMID: 36271283 DOI: 10.1038/s41598-022-22211-2] [Reference Citation Analysis]
4 Ma Y, Yang J, Ji T, Wen F. Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Front Genet 2022;13:990623. [DOI: 10.3389/fgene.2022.990623] [Reference Citation Analysis]
5 Jiang L, Li X, Wang S, Yuan Z, Cheng J. The role and regulatory mechanism of m6A methylation in the nervous system. Front Genet 2022;13:962774. [DOI: 10.3389/fgene.2022.962774] [Reference Citation Analysis]
6 Chen F, Xie X, Chao M, Cao H, Wang L. The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma. Front Immunol 2022;13:917153. [DOI: 10.3389/fimmu.2022.917153] [Reference Citation Analysis]
7 Liu W, Liu C, Wang H, Xu L, Zhou J, Li S, Cheng Y, Zhou R, Zhao L. Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy. Computational and Structural Biotechnology Journal 2022;20:5150-61. [DOI: 10.1016/j.csbj.2022.09.017] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345